![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Glatzel M. Ott P.M. Linder T. Gebbers J.O. Gmur A. Wust W. Huber G. Moch H. Podvinec M. Stamm B. Aguzzi A.
Publisher: Elsevier
ISSN: 1474-4422
Source: Lancet Neurology, Vol.2, Iss.12, 2003-12, pp. : 757-763
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cerebrospinal fluid biomarkers in human prion diseases
Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Human prion diseases: progress in clinical trials
By Zerr Inga
Brain, Vol. 136, Iss. 4, 2013-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Rudge P.
Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 3, 1997-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By McKintosh Edward Tabrizi Sarah J Collinge John
Journal of NeuroVirology, Vol. 9, Iss. 2, 2003-04 ,pp. :